Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

TAZICEF - ADD-VANTAGE How Supplied/Storage and Handling (ceftazidime for injection, USP - ADD-VANTAGE)


Tazicef in the dry state should be stored at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature] and protected from light. Tazicef (ceftazidime for injection, USP) is a dry, white to off-white powder supplied in ADD-Vantage® vials as follows:

Unit of SaleConcentration
NDC 0409-5092-16
25 single-dose ADD-Vantage® vials in a carton1 g/vial
NDC 0409-5093-11
10 single-dose ADD-Vantage® vials in a carton2 g/vial
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event